1972
DOI: 10.1038/newbio235017a0
|View full text |Cite
|
Sign up to set email alerts
|

Stereochemistry of Intercalation: Interaction of Daunomycin with DNA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

9
101
0
3

Year Published

1980
1980
2015
2015

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 276 publications
(113 citation statements)
references
References 13 publications
9
101
0
3
Order By: Relevance
“…intercalating agent that inhibits DNA synthesis (23,24), and its effect on cell membranes as the first target of action was also reported (25,26). Because the cycle of the pituitary cells is rather long, the damaging effect of DOX and its derivatives may be detectable by an impairment of cell functions other than mitotic division.…”
Section: Discussionmentioning
confidence: 99%
“…intercalating agent that inhibits DNA synthesis (23,24), and its effect on cell membranes as the first target of action was also reported (25,26). Because the cycle of the pituitary cells is rather long, the damaging effect of DOX and its derivatives may be detectable by an impairment of cell functions other than mitotic division.…”
Section: Discussionmentioning
confidence: 99%
“…It is believed that the inhibitory effect of this compound on both normal and tumour cell growth is due to its interference with RNA synthesis by binding directly to the double-stranded DNA template [2]. X-Ray fiber diffraction studies are believed to support a binding model in which intercalation between DNA base pairs, with consequent helix unwinding, plays an important role [3]. The crystallographic analysis of doxorubicin has not been determined.…”
Section: Introductionmentioning
confidence: 99%
“…Consistent with this, we found that CPT treatment in our system also led to an acute increase in intracellular temperature ( Figure 1E, 1G and Supplementary information, Figure S4). Interestingly, in a separate experiment, we found that another chemotherapeutic drug, doxorubicin (at 50 µM final concentration), which is a topoisomerase II inhibitor [9], did not cause any obvious intracellular temperature change ( Figure 1E and 1G). Thus, the distinct effect of these two drugs on cellular temperature likely reflects fundamental differences in their action mechanisms, the details of which remain to be further investigated.…”
mentioning
confidence: 98%